HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,857,543 | +12.5% | 24,700 | 0.0% | 0.06% | +18.0% |
| Q2 2023 | $2,540,395 | -5.8% | 24,700 | 0.0% | 0.05% | -7.4% |
| Q1 2023 | $2,695,758 | -5.9% | 24,700 | -1.8% | 0.05% | -6.9% |
| Q4 2022 | $2,863,777 | -81.7% | 25,165 | -90.0% | 0.06% | -82.7% |
| Q3 2022 | $15,645,000 | -26.1% | 252,786 | -4.7% | 0.34% | -20.8% |
| Q2 2022 | $21,167,000 | -24.2% | 265,380 | 0.0% | 0.42% | -8.0% |
| Q1 2022 | $27,921,000 | -2.4% | 265,380 | 0.0% | 0.46% | +7.7% |
| Q4 2021 | $28,597,000 | -1.7% | 265,380 | -0.0% | 0.43% | -4.3% |
| Q3 2021 | $29,078,000 | +41.6% | 265,455 | +21.0% | 0.45% | +44.3% |
| Q2 2021 | $20,536,000 | -25.7% | 219,310 | -27.0% | 0.31% | -30.2% |
| Q1 2021 | $27,637,000 | +25.8% | 300,275 | -0.0% | 0.44% | +19.1% |
| Q4 2020 | $21,969,000 | +1313.7% | 300,330 | +1401.6% | 0.37% | +1140.0% |
| Q3 2020 | $1,554,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |